EUVIMED · CrossrefZeitschrift
eGastroenterology
ISSN 2976-7296 · BMJ
Neueste Artikel
Early decline in anti-integrin αvβ6 autoantibodies strongly predicts 1-year clinical remission in vedolizumab-treated patients with ulcerative colitis
Targeting the IL-23 pathway in inflammatory bowel disease: from cytokine inhibition to oral IL-23 receptor blockade
From static labels to dynamic trajectories: MASLD–MetALD–ALD as a dynamic continuum within the framework of steatotic liver disease
Phosphoinositide kinase PIKfyve inhibitor apilimod blocks hepatitis E virus infection
Role of SQSTM1/p62 in regulating Mallory-Denk body in alcohol-associated liver disease
Autophagy related 14 protects against liver injury by inhibiting multiple cell death pathways
CD47: an immunoregulatory nexus in liver and gastrointestinal disorders
Regulatory T cells in liver metastases: emerging and divergent roles in tumour progression
Metabolic dysfunction and alcohol-associated liver disease (MetALD)
Immunotherapy against colorectal cancer via delivery of anti-PD-L1 nanobody mRNA
Steatotic liver disease and cancer: from pathogenesis to therapeutic targets
Ursodeoxycholic acid acts as an ileal FXR agonist in male mice with hepatic deficiency of FXR
Epigenetic mechanisms involved in hepatocellular carcinoma development and progression
Contribution of colibactin-producing Escherichia coli to colonic carcinogenesis
Pentoxifylline use in alcohol-associated hepatitis with acute kidney injury does not improve survival: a global study
Characterisation of macrophages in healthy and diseased livers in mice: identification of necrotic lesion-associated macrophages
Key takeaways from the updated multidisciplinary European MASLD guidelines
Periodontal disease and cirrhosis: current concepts and future prospects
Bacterial dysbiosis and decrease in SCFA correlate with intestinal inflammation following alcohol intoxication and burn injury
Gasdermin D deletion prevents liver injury and exacerbates extrahepatic damage in a murine model of alcohol-induced ACLF
Protein tyrosine phosphatase delta is a STAT3-phosphatase and suppressor of metabolic liver disease
Cell-to-cell and organ-to-organ crosstalk in the pathogenesis of alcohol-associated liver disease
New therapeutic target for alcohol-associated hepatitis (AH): AH-associated IL-8 + neutrophils
Endocrine pathology in young rabbits with cystic fibrosis
Mechanistic role of long non-coding RNAs in the pathogenesis of metabolic dysfunction-associated steatotic liver disease and fibrosis
Evidence-based incorporation of key parameters into MELD score for acute-on-chronic liver failure
Drug-target Mendelian randomisation applied to metabolic dysfunction-associated steatotic liver disease: opportunities and challenges
Characterisation of HBV and co-infection with HDV and HIV through spatial transcriptomics
Causal role of the gut microbiome in certain human diseases: a narrative review
Artificial intelligence-enabled advanced endoscopic imaging to assess deep healing in inflammatory bowel disease
EUVIMED